| Metric | შპს ჯორჯიან ფარმაცევტიკალსი | შპს საფ ფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾7.9m₾6.6m | ₾6.4m₾6.5m |
| Revenue growth | 18.9% | -1.3% |
| Profitability | ||
| EBITDA | ₾2.8m₾1.9m | ₾1.4m₾1.2m |
| EBITDA margin | 35.4%29.4% | 22.5%18.4% |
| Net profit | ₾2.6m₾1.4m | ₾1.5m₾1.1m |
| Net margin | 33.6%20.8% | 23.0%17.7% |
| Balance sheet | ||
| Total assets | ₾7.9m₾5.6m | ₾5.3m₾5.4m |
| Total equity | ₾7.9m₾5.1m | ₾2.7m₾1.2m |
| ROE | 33.5%27.0% | 54.6%93.9% |